Philippe Rochigneux, MD, on Solid Tumors: Use of Chemotherapy Near the End of Life

2016 ESMO Congress
Tweet this page

Philippe Rochigneux, MD, of the Paoli Calmettes Institute, Marseille Cancer Center, discusses his findings on the high rates of chemotherapy used at the end of life for metastatic solid cancer, especially in young patients treated in high-volume centers without a palliative care unit. (Abstract 1300O)

Advertisement

Advertisement



Advertisement